Department of Maternal-Infant and Urological Sciences, "Sapienza" Rome University, Policlinico Umberto I Hospital, Rome, Italy.
Department of Urology, Stanford University School of Medicine, Stanford, California, USA.
Andrologia. 2022 Jul;54(6):e14409. doi: 10.1111/and.14409. Epub 2022 Mar 3.
Some studies suggest a relationship between semen quality and pregnancy rates of assisted reproduction technologies (ART). Others have questioned the utility of semen quality as proxy for fertility in couples attempting to conceive with or without assistance. We aimed to investigate the current body of evidence which correlates semen parameters and clinical pregnancy among couples utilizing ART (i.e. in vitro fertilization [IVF], intracytoplasmic sperm injection [ICSI]) through a systematic review and meta-analysis of cross-sectional and retrospective cohort studies. Pooled Odd Ratio (OR) for oligo-, astheno- and teratospermic compared to normospermic number of ART cycles were calculated among. Meta-regression and sub-group analysis were implemented to model the contribution of clinical/demographic and laboratory standards differences among the studies. Overall, 17 studies were analysed representing 17,348 cycles were analysed. Pooled OR for impaired sperm concentration, motility and morphology was 1 (95%Confidence Interval [CI]: 0.97-1.03), 0.88 (95%CI: 0.73-1.03) and 0.88 (95%CI: 0.75-1) respectively. Further analysis on sperm morphology showed no differences with regard of IVF versus ICSI (p = 0.14) nor a significant correlation with rising reference thresholds (Coeff: -0.02, p = 0.38). A temporal trend towards a null association between semen parameters and clinical pregnancy was observed over the 20-year observation period (Coeff: 0.01, p = 0.014). The current analysis found no association between semen quality (as measured by concentration, motility or morphology) and clinical pregnancy rates utilizing ART. Future investigations are necessary to explore the association between semen parameters and other ART outcomes (e.g. fertilization, implantation, birth and perinatal health).
一些研究表明,精液质量与辅助生殖技术(ART)的妊娠率之间存在一定关系。也有其他研究对精液质量作为有生育能力的夫妇在接受或不接受辅助生育治疗时的代理指标的效用提出了质疑。我们旨在通过对横断面和回顾性队列研究的系统评价和荟萃分析,调查当前与利用 ART(即体外受精[IVF]、胞浆内精子注射[ICSI])相关的精液参数与临床妊娠之间的证据。计算了与正常精子数量相比,少精症、弱精症和畸形精症的 ART 周期中每个 OR。采用元回归和亚组分析来模拟研究中临床/人口统计学和实验室标准差异的影响。总体而言,分析了 17 项研究,代表了 17348 个周期。精液浓度、活力和形态受损的汇总 OR 分别为 1(95%置信区间[CI]:0.97-1.03)、0.88(95%CI:0.73-1.03)和 0.88(95%CI:0.75-1)。进一步对精子形态的分析表明,IVF 与 ICSI 之间没有差异(p=0.14),也与参考阈值的升高没有显著相关性(系数:-0.02,p=0.38)。在 20 年的观察期内,观察到精液参数与临床妊娠之间的关联呈时间趋势向零关联(系数:0.01,p=0.014)。目前的分析发现,精液质量(通过浓度、活力或形态来衡量)与利用 ART 的妊娠率之间没有关联。未来的研究有必要探索精液参数与其他 ART 结果(如受精、着床、出生和围产期健康)之间的关系。